Abstract Details
Rani A. Sarkis, MD, MSc
(Brigham and Women'S)
PRESENTER |
Dr. Sarkis has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Philip De Jager, MD, PhD (Columbia University Irving Medical Center) | Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from Biogen. The institution of Dr. De Jager has received research support from puretech. |
Page B. Pennell, MD, FAAN (University of Pittsburgh School of Medicine) | The institution of Dr. Pennell has received research support from NIH. Dr. Pennell has received publishing royalties from a publication relating to health care. |
No disclosure on file | |
Wassim Elyaman, PhD | Dr. Elyaman has nothing to disclose. |